Chapter 22: Cystic Fibrosis Flashcards
1
Q
Etiology of Cystic Fibrosis
A
- autosomal reccessive disorder of exocrine glands
- most common genetic lung disease in the US
- classified as airflow or suppurative (pus-forming)
- hypersecretion of abnormal, thick mucus that obstructs exocrine glands and ducts
- median survival age is about 31 years
2
Q
Pathogenisis of cystic fibrosis
A
- Dysfunction of CFTR gene
- Primarily affects the pancreas, intestinal tract, sweat glands, and lungs, and in males causes infertility
- high concentrations of sodium and chloride in sweat, salivary, and lacrimal secretions (results in salty skin)
- mucus producing glands in the GI tract enlarge
- bronchopulmonary system is also affected by the thick, tenacious mucus
3
Q
Pathogenesis of Cysitic Fibrosis (dysfunction of CFTR gene)
A
- normally CFTR encodes a membrane chloride channel and is in sweat glands, lungs, and pancreas
- CFTR gene mutations result in alteration in chloride and water transport across epithelial cells
4
Q
Pathogenesis of Cysitic Fibrosis (mucus producing glands in GI tract enlarge)
A
- generates excessive secretions
- thick eosinophillic mucuous secretions plug the glands and ducts of the GI tract, causing dilation and fibrosis
- leads to decreased production of pancreatic enzymes, causing increased fat and protein in stool
5
Q
Pathogenesis of Cysitic Fibrosis (Bronchopulmonary system affected)
A
- failure of chloride channels to function
- decreased flow of ions and water results in viscid (thick) mucus
- causes airway obstruction, ateletasis (collapse of alveoli) and hyperinflation and also decreases cilliary action (bc mucus)
- Provides a medium for pulmonary infection (pseudomonas staph)
6
Q
Clinical Manifestations of Cystic Fibrosis (lung related)
A
- history of cough in young adult or child
- thick, tenacious sputum
- recurretn pulmonary infections and bronchitis
- Dyspnea, tachypnea
- Sternal retractions
- Unequal Breath sounds
- moist basilar crackles and rhonchi
- Barrel chest hyperresonant to percussion
- DIgital clubbing (late)
7
Q
Clinical manifestations of Cystic Fibrosis (other)
A
- pancreatic insufficiency
- cirrhosis of the liver
- diabetes mellitus
- gallstones
- nasal pollyps
- failure of development of the vas deferens in males
- Nutrional assesment includes depleted fat stores, Steatorrhea (fatty stools), anorexia, and decreased growth rate in children
8
Q
Diagnosis of Cystic Fibrosis
A
- ABG (hypoxemia and hypercapnia (unable to breath enough to get rid of CO2))
- PFT ( Decreased VC, airflow, and TV; Increased airway resistance, functional residual capacity)
- Chest xray (patchy atelectasis, bronchiectasis, cystic lung fields)
- sputum culture and sensitivity
- 72 hr stool collection (fat absorption and secretion)
- Genetic testing (marker AF-508 confirms diagnosis)
9
Q
Treatment of Cystic Fibrosis
A
- aggressive treatment of respiratory infections
- postural drainage and chest physiotherapy (chest percussion)
- Forced expiratory technique
10
Q
Medicinal Treatment of Cystic FIbrosis
A
- Bronchodilators
- Recombinant human deoxyribonuclease 1 (dornase alfa): digest extracellular DNA present in the viscid sputum
- High dose antibiotics
- Influenza Vaccine
11
Q
Nutritional Therapy for Cystic Fibrosis
A
- unrestricted fat consumption; 30% of caloric intake
- high protein
- vitamin supplements, esp A, K, D, & E
- Pancreatic Enzymes
- Intake of 150% of normal caloric intake
- May need enteral feedings or IV (through tube)
- may need heart or lung transplant